Market Overview
Surgical Staplers Market size is expected to grow at a CAGR of 8.22% during the forecast period (2024-2031).
A surgical stapler is a medical device used during a surgical procedure. These devices are versatile and highly efficient and have advanced safety parameters to overcome postoperative complications that often occur due to staple line leaks.
The surgical stapler is available for wound closure and thoracic and intraabdominal resections. The primary advantage of a surgical stapler is that it saves time and provides more conventional surgical techniques in closure compared to traditional surgical techniques. Surgical staplers were developed to address complications during the healing period of traditional sutures. However, the introduction of surgical staplers provided many advantages, such as speed, accuracy, and consistency in the closure of wounds. This made the surgical stapler an important tool in the operating room.
Market Summary
| Metrics | Details |
| Market CAGR | 8.22% |
| Segments Covered | By Product Type, By Application, By Technology, By Usage Type, By End-Users, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Download Sample
Market Dynamics
The increasing prevalence of surgical procedures is expected to drive market growth.
Surgical procedures increased by 54%, while non-surgical procedures grew by 44%. Body procedures increased more than any other segment, led by increases in liposuction and abdominoplasty procedures. In 2021, the typical plastic surgeon conducted 320 surgical procedures, up from 220 in 2020. Moreover, the average cost of a surgical procedure rose by 6% in 2021, while the cost of a non-surgical procedure rose by 1%.
Approximately 94% of the procedures were performed on women. In 2021, 365,000 breast augmentations were performed. Furthermore, 148,000 women had their implants removed and replaced (+32% from 2020), whereas 71,000 had removed but not replaced. Despite accounting for only 21% of total treatments, surgical procedures accounted for 69% of total income. Therefore, it has increased the adoption of surgical staplers. Thus, from the above statements, the market is expected to drive in the forecast period.
Restraint
The high cost associated with the devices, availability of alternative wound care techniques, adverse events, and product issues with surgical staplers is expected to hamper the market in the forecast period.
Market Segmentation Analysis
Powered surgical staplers segment is expected to hold the largest market share in the surgical staplers market.
The powered surgical staplers segment accounted for the largest market share in 2021. The segment is beneficial because of numerous benefits these staplers offer, including proper wound closure, fewer leaks, stability and less compressive force. The increased research and development activities to improve powered surgical staplers' operational capabilities will open new avenues for industry progression. Also, ease of use and reduced hospitalization cost compared to manual staplers will fuel the market growth. Moreover, the launch of new products and regulatory approval for powered surgical staplers are the factors the market is boosted in the forecast period.
For instance, on April 5, 2021, Ethicon launched the Echelon+ stapler with gripping surface technology (GST) reloads. Echelon+ is intended to improve staple line security and prevent problems by providing more uniform tissue compression and improved staple formation in difficult settings. Therefore, there is an increase in the demand for powered surgical staplers. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
Market Geographical Share
North American region is expected to hold the largest market share in the global surgical staplers market.
North America accounted for the largest market share in 2021. Growing geriatric population, an increasing number of surgeries for corrective and preventive treatments, increasing preference for bariatric and cosmetic surgeries, availability of technologically advanced products, and the presence of leading surgical stapler manufacturers in the region. For instance, on June 6, 2022, the ECHELON 3000 Stapler, a digitally enabled equipment that enables surgeons with simple, one-handed powered articulation to help address their patients' individual demands, was launched in the United States by Ethicon, a division of Johnson & Johnson MedTech.
With a 39% larger jaw aperture and a 27% larger articulation span, the ECHELON 3000 provides surgeons better access and control over each transaction, even in small areas and on difficult tissue. When these capabilities are paired with software that offers real-time haptic and audio device feedback, surgeons can make essential adjustments during procedures. Therefore, there is an increase in the demand for a surgical staplers in the region. Thus, from the above statements, the North American region holds the largest market share in the forecast period.
Companies and Competitive Landscape
Major key players in the surgical staplers market are Medtronic plc, Johnson & Johnson Company, 3M Company, B. Braun Melsungen AG, Reach Surgical Inc., Intuitive Surgical Inc., CONMED Corporation, Teleflex Inc., Waston Medical Co., Ltd, Purple Surgical Ltd.
Medtronic plc:
Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.
Product Portfolio:
GIA Stapler with Tri-Staple Technology: Tri-Staple technology is an open linear stapler. It consistently assists surgeons in improving patient outcomes. Compared to a two-row stapler, the staple line leak pressure is higher. Less tissue stress during compression and clamping. A sloped cartridge face with varying height staples may improve staple line perfusion. Consistent performance across a wide tissue thickness range.
The global surgical staplers market report would provide an access to an approx. 45+market data table, 40+figure
